Cardinal Health Inc. raised its full-year profit projections by 20 cents per share after beating expectations in the fourth ...

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds.

Q1 2025 Earnings Call Transcript November 1, 2024 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.88, ...

Optimum was a top customer whose contract expired at the end of June. Excluding that, 1Q sales saw double-digit annual growth ...

Leerink Partners analyst Michael Cherny has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday. Michael Cherny has ...

Cardinal Health (NYSE:CAH – Get Free Report) had its price target increased by investment analysts at Morgan Stanley from ...

In a report released on November 1, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), ...

The company struck a $1.12 billion deal in September to buy community cancer center operator Integrated Oncology Network to ...

Shares of Cardinal Health Inc. CAH inched 0.90% higher to $121.64 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index ...

Cardinal Health (NYSE:CAH – Get Free Report) had its price target hoisted by analysts at Barclays from $117.00 to $133.00 in ...

Pharmaceuticals, medical and laboratory products distributor Cardinal Health opened a new distribution center in Boylston, MA ...